170 related articles for article (PubMed ID: 29959216)
1. Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability.
Falzone N; Lee BQ; Able S; Malcolm J; Terry S; Alayed Y; Vallis KA
J Nucl Med; 2018 Jun; 60(2):250-8. PubMed ID: 29959216
[TBL] [Abstract][Full Text] [Related]
2. Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.
Mellhammar E; Dahlbom M; Vilhelmsson-Timmermand O; Strand SE
J Nucl Med; 2023 Oct; 64(10):1632-1637. PubMed ID: 37934033
[TBL] [Abstract][Full Text] [Related]
3. Large-scale in vitro microdosimetry via live cell microscopy imaging: implications for radiosensitivity and RBE evaluations in alpha-emitter radiopharmaceutical therapy.
Bastiaannet R; Liatsou I; F Hobbs R; Sgouros G
J Transl Med; 2023 Feb; 21(1):144. PubMed ID: 36829143
[TBL] [Abstract][Full Text] [Related]
4. On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and ¹²³I.
Freudenberg R; Runge R; Maucksch U; Berger V; Kotzerke J
Med Phys; 2014 Jun; 41(6):062503. PubMed ID: 24877837
[TBL] [Abstract][Full Text] [Related]
5. A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.
Hobbs RF; Baechler S; Fu DX; Esaias C; Pomper MG; Ambinder RF; Sgouros G
Med Phys; 2011 Jun; 38(6):2892-903. PubMed ID: 21815364
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dose distribution calculation at nuclear level for Auger-emitting radionuclide energies.
Di Maria S; Belchior A; Romanets Y; Paulo A; Vaz P
Appl Radiat Isot; 2018 May; 135():72-77. PubMed ID: 29413839
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
[TBL] [Abstract][Full Text] [Related]
8. Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).
Ballangrud AM; Yang WH; Charlton DE; McDevitt MR; Hamacher KA; Panageas KS; Ma D; Bander NH; Scheinberg DA; Sgouros G
Cancer Res; 2001 Mar; 61(5):2008-14. PubMed ID: 11280760
[TBL] [Abstract][Full Text] [Related]
9. A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT).
Spoormans K; Crabbé M; Struelens L; De Saint-Hubert M; Koole M
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297446
[TBL] [Abstract][Full Text] [Related]
10. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
11. Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling.
Buffa FM; West C; Byrne K; Moore JV; Nahum AE
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1109-18. PubMed ID: 11240253
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.
Falzone N; Fernández-Varea JM; Flux G; Vallis KA
J Nucl Med; 2015 Sep; 56(9):1441-6. PubMed ID: 26205298
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
[TBL] [Abstract][Full Text] [Related]
14. Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.
Shinohara A; Hanaoka H; Sakashita T; Sato T; Yamaguchi A; Ishioka NS; Tsushima Y
Ann Nucl Med; 2018 Feb; 32(2):114-122. PubMed ID: 29238922
[TBL] [Abstract][Full Text] [Related]
15. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations.
Pacilio M; Lanconelli N; Lo MS; Betti M; Montani L; Torres AL; Coca PM
Med Phys; 2009 May; 36(5):1543-52. PubMed ID: 19544770
[TBL] [Abstract][Full Text] [Related]
16. Membrane and Nuclear Absorbed Doses from
Larouze A; Alcocer-Ávila M; Morgat C; Champion C; Hindié E
J Nucl Med; 2023 Oct; 64(10):1619-1624. PubMed ID: 37321819
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity of Auger electron-emitting [
Othman MFB; Verger E; Costa I; Tanapirakgul M; Cooper MS; Imberti C; Lewington VJ; Blower PJ; Terry SYA
Nucl Med Biol; 2020; 80-81():57-64. PubMed ID: 31889612
[TBL] [Abstract][Full Text] [Related]
19. Specific absorbed fractions and radionuclide S-values for tumors of varying size and composition.
Olguin E; President B; Ghaly M; Frey E; Sgouros G; Bolch WE
Phys Med Biol; 2020 Dec; 65(23):235015. PubMed ID: 32992308
[TBL] [Abstract][Full Text] [Related]
20. Predicting response of micrometastases with MIRDcell V3: proof of principle with
Katugampola S; Wang J; Prasad A; Sofou S; Howell RW
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):3989-3999. PubMed ID: 35802160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
